Ipsen Logo

Ipsen announces positive phase 3 results in limb spastic hemiparesis

pharmafile | September 24, 2019 | News story | Manufacturing and Production, Research and Development  

Ipsen has announced results from its ENGAGE study for the combination of Dysport (abobotulinumtoxinA) alongside Guided Self-rehabilitation contracts (GSC) which both improved patients voluntary movement as measured by a composite active range of motion outcome.

ENGAGE si the first study to investigate treatment with Dysport in patients with spastic hemiparesis in both the upper and lower limbs in combination with GSC.

Professor Jean-Michel Gracies, primary investigator for ENGAGE, said: “This study provides insight into treatment strategies that can improve the outcomes of patients living with spastic paresis, specifically the role of Guided Self-rehabilitation Contracts combined with Dysport for the improvement of voluntary movement, an area of limited data availability.

“Importantly, stronger active motion improvements and a longer time to reinjection was seen in ENGAGE versus previous Dysport studies, which suggests a synergistic effect of adding a GSC intervention to treatment with Dysport for patients with UL and LL spasticity.”

Anthony Fulford-Smith, Vice President of Medical Affairs, Neuroscience, and R&D at Ipsen, said: “Over the last two decades there has been a shift from patients being recipients of healthcare to active participants empowered in their own health journey.

“Through ENGAGE, we have been able to demonstrate for the first time the benefit of combining treatment with Dysport with a systematic rehabilitation protocol, validating the positive impact of encouraging patients to take an active role in their own treatment.

“At Ipsen, we are constantly searching for ways to improve disease management and comprehensive care with a patient-centred approach. By using active range of motion as its primary measure, ENGAGE offers important insights on the potential benefit of using Dysport with GSC combination therapy in the context of meaningful functional outcomes for patients.”

Spastic hemiplegia is caused by brain damage which occurred in the womb or during birth. It can also occur shortly after birth. It is a neuromuscular condition of spasticity that results in the muscles on one side of the body being in a constant state of contraction.

Nik Kiran

Related Content

No items found

Latest content